Callan JMB Inc. Common Stock (CJMB) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Callan JMB Inc. Common Stock (CJMB) has a cash flow conversion efficiency ratio of -1.050x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-1.68 Million) by net assets ($1.60 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See defensive interval ratio of Callan JMB Inc. Common Stock to measure how many days the company can operate on defensive assets alone.
Callan JMB Inc. Common Stock - Cash Flow Conversion Efficiency Trend (2022–2025)
This chart illustrates how Callan JMB Inc. Common Stock's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Callan JMB Inc. Common Stock Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Callan JMB Inc. Common Stock ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Brüder Mannesmann Aktiengesellschaft
F:BMM
|
-0.171x |
|
Sky Quarry Inc
NASDAQ:SKYQ
|
-0.405x |
|
Traka Resources Ltd
AU:TKL
|
6.791x |
|
Gungnir Resources Inc
V:GUG
|
-0.011x |
|
MEMPHASYS LTD
F:IG7
|
N/A |
|
Bang Overseas Limited
NSE:BANG
|
-0.049x |
|
CASI Pharmaceuticals Inc
NASDAQ:CASI
|
0.029x |
|
NCL International Logistics Public Company Limited
BK:NCL
|
-0.560x |
Annual Cash Flow Conversion Efficiency for Callan JMB Inc. Common Stock (2022–2025)
The table below shows the annual cash flow conversion efficiency of Callan JMB Inc. Common Stock from 2022 to 2025. For the full company profile with market capitalisation and key ratios, see market value of Callan JMB Inc. Common Stock.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $2.33 Million | $-4.55 Million | -1.953x | -1246.96% |
| 2024-12-31 | $3.17 Million | $540.35K | 0.170x | -78.59% |
| 2023-12-31 | $8.80 Million | $7.00 Million | 0.795x | +19.02% |
| 2022-12-31 | $14.01 Million | $9.36 Million | 0.668x | -- |
About Callan JMB Inc. Common Stock
Callan JMB Inc., through its subsidiary, Coldchain Technology Services, LLC provides thermal management logistics solutions to the life sciences industry in United States. It offers logistics solutions and services utilized for frozen shipping in the life sciences industry, including personalized medicine, cell therapies, stem cells, cell lines, vaccines, diagnostic materials, semen, eggs, embryo… Read more